Nuclear medicine congress
Congress marks watershed moment for nuclear medicine and ANSTO
Showing 61 - 80 of 166 results
Congress marks watershed moment for nuclear medicine and ANSTO
Low-cost X-ray detectors featuring high sensitivity, durability and physical flexibility are required in fields ranging from medical imaging to defence. In this study, a new material for X-ray detection was coupled with inkjet printing to produce a series of prototype X-ray detectors.
Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.
With enhanced submicron spatial resolution, speed and contrast, the Micro-Computed Tomography beamline opens a window on the micron-scale 3D structure of a wide range of samples relevant to many areas of science including life sciences, materials engineering, anthropology, palaeontology and geology. MCT will be able to undertake high-speed and high-throughput studies, as well as provide a range of phase-contrast imaging modalities.
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
Biochemical and structural studies to elucidate protein interactions of the new compounds and target molecules included X-ray diffraction at the Australian Synchrotron.
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
Research on lunar meteorite and moon crater analogues coincides with Science Week.
ANSTO and the National University of Singapore have signed an agreement to enable Singapore researchers to access ANSTO’s state-of-the-art beamline facilities at the Australian Synchrotron.